AtlantiCare Selects MEDai’s Predictive Analytics Solutions
Health Engagement program to use MEDai’s Risk Navigator as tool in coordinating care delivery
Orlando, FL – 4 April, 2011 – AtlantiCare, the largest health system in southeastern New Jersey, will allow its healthcare providers to better manage patient populations and track clinical and financial objectives with quality-focused tools from Elsevier/MEDai, a leading provider of predictive analytic solutions.
AtlantiCare’s vision is to build healthy communities. It will use MEDai’s Risk Navigator solutions to provide analytics for its Health Engagement program, which is positioned to prevent injury and illness, and manage health risks, chronic illnesses and healthcare utilization. Additionally, AtlantiCare is part of Premier, a collaborative to design and implement an Accountable Care Organization (ACO) in New Jersey. ACOs are designed to keep patients healthy and out of intensive care settings, while simultaneously shifting reimbursements to be based on quality outcomes and efficiencies.
AtlantiCare will use MEDai’s Risk Navigator solutions in conjunction with its patient-centered medical home model toenhance cooperation and communication between plan, provider and nurse case managers. Risk Navigator provides the ability to integrate data from multiple sources and systems and produce information that is needed to provide proactive patient care.
“The collaborative nature of ACOs is an extremely important step in the evolution of our nation’s healthcare systems,” said Clayton Ramsey, COO, MEDai. “MEDai’s predictive analytics and healthcare expertise aid clients in ensuring they have the necessary resources to make quality, efficient patient-care decisions based on accurate information.”
For more than a decade, MEDai’s predictive modeling suite has accurately forecasted prospective high-risk patients to improve patients' health and quality of care while controlling cost. Risk Navigator Clinical is built to fit the clinical workflow by wrapping business intelligence around a member-centric database providing evidence-based medicine guideline compliance information and cost and utilization forecasts. Clients can also leverage MEDai’s motivation index to determine the level of member engagement most appropriate based on the members’ motivation to self manage their conditions.
# # #
MEDai, Inc. is a subsidiary of Elsevier, a world-leading publisher of more than 2,000 scientific, technical and medical information products and services. MEDai offers award-winning solutions for the improvement of healthcare delivery. Utilizing cutting-edge technology, payors and care management organizations are able to predict patients at risk, identify cost drivers for their high-risk population, forecast future health plan costs, evaluate patient patterns over time and improve outcomes. For more information on MEDai, visit www.medai.com.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.Media Contact
Vice President of Global Relations, Elsevier